Concourse Financial Group Securities’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
Concourse Financial Group Securities's EBS Position: Q3 2023 in Review
Concourse Financial Group Securities sold out of Emergent Biosolutions (EBS) in Q3 2023, closing a stake of 6 shares — an estimated $33 sold.
Concourse Financial Group Securities first reported a position in EBS in Q3 2018 and held it in 18 quarters. The position peaked at $133K in Q4 2018. 161 funds tracked by Wall St. Rank hold EBS as of Q3 2023.
- Concourse Financial Group Securities reported no remaining Emergent Biosolutions position as of Q3 2023 after selling out during the quarter.
- Concourse Financial Group Securities sold 6 Emergent Biosolutions shares in Q3 2023, an estimated $33.
- Concourse Financial Group Securities first reported a position in Emergent Biosolutions in Q3 2018 and held it in 18 quarters.
- Concourse Financial Group Securities's Emergent Biosolutions position peaked at $133K in Q4 2018.
- 161 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2023.
Based on Concourse Financial Group Securities's 13F filing for Q3 2023, filed 25 Oct 2023.